These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3875634)

  • 1. Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes.
    Vlock DR; Kirkwood JM
    J Clin Invest; 1985 Aug; 76(2):849-54. PubMed ID: 3875634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration.
    Vlock DR; Scalise D; Schwartz DR; Richter DE; Krause CJ; Baker SR; Carey TE
    Cancer Res; 1989 Mar; 49(6):1361-5. PubMed ID: 2924293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
    Kirkwood JM; Vlock DR
    Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
    Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
    Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of antibody reactivity to melanoma.
    Vlock DR; DerSimonian R; Kirkwood JM
    J Clin Invest; 1986 Apr; 77(4):1116-21. PubMed ID: 3958183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlations between complement degradation products and circulating immune complexes in human glomerulonephritis].
    Coppo R; De Marchi M; Alloatti S; Segoloni G; Giacchino F; Quarello F; Roccatello D; Bulzomi MR; Piccoli G
    Minerva Nefrol; 1979; 26(3):243-50. PubMed ID: 318057
    [No Abstract]   [Full Text] [Related]  

  • 7. Serial studies of autologous antibody reactivity to squamous cell carcinoma of the head and neck.
    Vlock DR; Arnold B; Humpierres J; Schwartz DR; Baker SR; Krause CJ; Swanson N; Carey TE
    Cancer Immunol Immunother; 1992; 34(5):329-36. PubMed ID: 1540979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes in patients with melanoma.
    Sztaba-Kania M; Jassem J; Piskorzyńska M; Kondrat W
    Neoplasma; 1981; 28(4):491-6. PubMed ID: 7027060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between circulating immune complexes and renal disease in New Zealand mice.
    Nakai Y; Yoshida H; Maruyama N; Shirai T; Hamashima Y
    Clin Exp Immunol; 1981 Feb; 43(2):240-5. PubMed ID: 6974065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating immune complexes in the serum of tumor patients].
    Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
    Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential determination of circulating immune complexes during progressive and regressive phases of mouse mastocytoma.
    Bertschmann M; Späth PJ; Nydegger UE; Lüscher EF
    J Clin Lab Immunol; 1984 Nov; 15(3):149-54. PubMed ID: 6442352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
    Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
    J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complex levels in patients with gestational trophoblastic neoplasia.
    Rayner AA; Berkowitz R; Steele G; Schur PH; Rodrick ML; Goldstein DP; Harte PJ; Wilson RE; Zamcheck N; Munroe AE
    J Natl Cancer Inst; 1982 Jul; 69(1):23-6. PubMed ID: 6285061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes in breast cancer patients.
    Croce MV; Pasqualini RS; Segal-Eiras A
    Medicina (B Aires); 1987; 47(4):371-6. PubMed ID: 3502571
    [No Abstract]   [Full Text] [Related]  

  • 18. Serological evaluation of melanoma patients in a phase I/II trial of vaccinia melanoma oncolysate (VMO) immunotherapy.
    Wallack MK; Bash JA; McNally KR; Leftheriotis E
    Cancer Detect Prev Suppl; 1987; 1():351-9. PubMed ID: 3155379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic liver disease: the detection and characterization of circulating immune complexes.
    Brown SE; Steward MW; Viola L; Howard CR; Murray-Lyon IM
    Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
    Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
    J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.